Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Celestial Seasonings

This article was originally published in The Tan Sheet

Executive Summary

Net sales fell 5.3% to $35.7 mil. for the three months ended Dec. 31, due primarily to a 63.3% decline in dietary supplement sales from the year-ago period, the company reports in an SEC 10-Q filing. Supplement sales for the FY 2000 first quarter totaled $1.7 mil. In the previous quarter, the Boulder, Colo.-based specialty tea manufacturer ceased production of its 30-count supplement line and offered a return program to customers. Gross profit margin as a percent of net sales increased from 62.8% to 64.6% due to "a better tea product mix, improved efficiencies in manufacturing and lower sales of dietary supplements that generate lower gross margins"

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel